Lilly's NDA will likely include obesity as the primary indication, with knee osteoarthritis as a separate label indication a meaningful distinction that could influence insurance coverage pathways for OA patients who might not qualify on obesity grounds alone
Su QJ, Ashenhurst JR, Xu W, et al
Tsai PT, Hull C, Chu Y, Greene-Colozzi E, Sadowski AR, Leech JM, et al
Typically, Mounjaro prescription coverage requires a diabetes diagnosis, whereas Zepbound is more accessible for weight management needs through insurance
Puede aadir espinacas, brcoli, ajo, cebolla, nueces, almendras y t verde a su dieta
Even if this translates perfectly to humans (which in-vitro findings rarely do), a 38% reduction in DPP-4 would modestly extend GLP-1's half-life from about 2 minutes to perhaps 3-4 minutes